Spinal Fusion News and Research RSS Feed - Spinal Fusion News and Research

First Edition: February 25, 2014

Today's headlines include stories exploring the political dynamics governors face regarding the health law's Medicaid expansion. [More]
Sedation before nerve block significantly increases false-positive results, shows study

Sedation before nerve block significantly increases false-positive results, shows study

New research suggests that sedating patients before a nerve block needed to diagnose or treat chronic pain increases costs, risks and unnecessary surgeries, and sedation does nothing to increase patient satisfaction or long-term pain control. [More]

DePuy Synthes Spine signs representative agreement for marketing LifeNet Health's cellular allografts

DePuy Synthes Spine and DePuy Synthes Biomaterials, divisions of DePuy Orthopaedics, Inc., announced today they have entered into an exclusive worldwide representative agreement for the marketing and promotion of a new cellular allograft product developed by LifeNet Health, a world leader in allograft bio-implants and cellular therapies. [More]
DePuy Synthes Spine announces the U.S. launch of new tissue implant for spine fusion surgery

DePuy Synthes Spine announces the U.S. launch of new tissue implant for spine fusion surgery

DePuy Synthes Spine, in collaboration with DePuy Synthes Biomaterials, announced today the U.S. launch of CONFORM SHEET, a hydrated, pliable and totally demineralized cancellous bone matrix that fills voids during posterolateral spinal fusion surgery and provides a natural scaffold for new bone formation. [More]

DePuy Synthes develops CONFORM SHEET allograft implant for spinal fusion surgery

DePuy Synthes Spine, in collaboration with DePuy Synthes Biomaterials, announced today the U.S. launch of CONFORM SHEET™, a hydrated, pliable and totally demineralized cancellous bone matrix that fills voids during posterolateral spinal fusion surgery and provides a natural scaffold for new bone formation. [More]
Research roundup: Long-term care use varies dramatically by state; health spending slowdown explained

Research roundup: Long-term care use varies dramatically by state; health spending slowdown explained

In 2012, about 58,500 paid, regulated long-term care services providers served about 8 million people in the United States. Long-term care services were provided by 4,800 adult day services centers, 12,200 home health agencies, 3,700 hospices, 15,700 nursing homes, and 22,200 assisted living and similar residential care communities. Each day in 2012, there were 273,200 participants enrolled in adult day services centers, 1,383,700 residents in nursing homes, and 713,300 residents in residential care communities; in 2011, about 4,742,500 patients received services from home health agencies, and 1,244,500 patients received services from hospices. Provider sectors differed in ownership, and average size and supply varied by region (Harris-Kojetin et al., 12/12). [More]
Research paper provides first evidence-based recommendations for using PRP in orthopaedic care

Research paper provides first evidence-based recommendations for using PRP in orthopaedic care

Platelet-rich plasma (PRP) has grabbed headlines in recent years for its role in helping some of sports' biggest stars return to play following injury -including golfer Tiger Woods, Super Bowl winner Hines Ward and NBA legend Kobe Bryant. [More]

Questions about medical necessity for some surgeries, screenings

The Washington Post looks at the dramatic increase in spinal fusion surgeries and whether all are necessary, while Kaiser Health News examines screenings for stroke and heart disease, some of which are not recommended for healthy people. [More]

Amedica signs distribution agreement with K2M

Amedica Corporation, a biomaterial company, announced today that it has entered into a distribution agreement with K2M that will provide surgeons and hospitals in Europe with access to Amedica's Silicon Nitride interbody spinal fusion devices. [More]
BMP linked to increased risk of benign tumors, not cancers

BMP linked to increased risk of benign tumors, not cancers

Patients undergoing spinal fusion surgery with bone morphogenetic protein (BMP) appear to be at increased risk of benign tumors—but not cancers, reports a study in the September issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. [More]
Indicators of poor preoperative health predict risk of major medical complications

Indicators of poor preoperative health predict risk of major medical complications

For older adults undergoing surgery for spinal stenosis, some simple indicators of poor preoperative health predict a high risk of major medical complications, reports a study in the September 1 issue of Spine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. [More]
Professional athletes can return to competition after vertebral fusion surgery

Professional athletes can return to competition after vertebral fusion surgery

Most professional athletes are able to return to competition within a year after vertebral fusion surgery on the upper (cervical) spine, reports a study in the July issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. [More]
OHSU analysis finds previous studies have overstated effectiveness of bone growth product used in spinal surgeries

OHSU analysis finds previous studies have overstated effectiveness of bone growth product used in spinal surgeries

An analysis by the Evidence-based Practice Center at Oregon Health & Science University has found that previously published clinical trial studies about a controversial bone growth product used in spinal surgeries overstated the product's effectiveness. [More]

Study reports that less-invasive option for spinal stenosis poses 'trade-off' in outcomes

Interspinous spacer implantation-a less-invasive alternative surgical option for spinal stenosis-has a lower complication rate than spinal fusion, reports a study in the May 1 issue of Spine The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. [More]

RBCs stored longer than 3 weeks begin to lose the capacity to deliver oxygen-rich cells to tissue

A small study from Johns Hopkins adds to the growing body of evidence that red blood cells stored longer than three weeks begin to lose the capacity to deliver oxygen-rich cells where they may be most needed. [More]

New implantable sensor holds promise for advancing personalized medicine

Rebecca Wachs has invented a new implantable sensor with the ability to wirelessly transmit data from the site of a knee replacement, spinal fusion, or other orthopedic surgery. [More]

Study looks at natural history of cervical spondylolisthesis

Follow-up data on patients with degenerative disease of the upper (cervical) spinal vertebrae show little or no evidence of worsening degeneration over time, according to a study in the February 15 issue of Spine. [More]
FDA approves K7 LLC's K7C Cervical Spacer for use as IBF device

FDA approves K7 LLC's K7C Cervical Spacer for use as IBF device

K7 LLC's K7C Cervical Spacer, a spinal implant device using Evonik's VESTAKEEP PEEK (polyetheretherketone), has received the U.S. Food and Drug Administration's (FDA) 510(k) approval for use as an Intervertebral Body Fusion (IBF) device. [More]

Study finds negligible effect on periprocedural outcomes among patients after spine surgery

The "July effect"-the notion that the influx of new residents and fellows at teaching hospitals in July of each year adversely affects patient care and outcomes-was examined in a very large data set of hospitalizations for patients undergoing spine surgery. Researchers at the Mayo Clinic and the University of Virginia Health System found a negligible effect on periprocedural outcomes among patients treated by spine surgery. [More]
Cervical disc replacement: an interview with Joe Ross, VP of U.S. Marketing at LDR

Cervical disc replacement: an interview with Joe Ross, VP of U.S. Marketing at LDR

Cervical disc replacement is a surgical procedure that involves removing a damaged or degenerated cervical disc and replacing it with an artificial disc device. [More]